 Girish Shirali
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 35 | 2020 | 67 | 7.960 |
Why?
| | Echocardiography | 36 | 2020 | 58 | 6.010 |
Why?
| | Echocardiography, Three-Dimensional | 24 | 2018 | 25 | 5.560 |
Why?
| | Heart Ventricles | 20 | 2019 | 32 | 4.400 |
Why?
| | Ventricular Dysfunction, Left | 12 | 2017 | 14 | 2.610 |
Why?
| | Cardiac Catheterization | 15 | 2020 | 16 | 2.390 |
Why?
| | Humans | 100 | 2021 | 5931 | 2.300 |
Why?
| | Pulmonary Valve Insufficiency | 6 | 2020 | 6 | 2.200 |
Why?
| | Ventricular Function, Left | 13 | 2019 | 19 | 1.950 |
Why?
| | Cardiac Surgical Procedures | 13 | 2016 | 21 | 1.860 |
Why?
| | Heart Transplantation | 10 | 2017 | 12 | 1.830 |
Why?
| | Pediatrics | 9 | 2016 | 192 | 1.710 |
Why?
| | Pulmonary Valve | 6 | 2020 | 6 | 1.680 |
Why?
| | Infant | 39 | 2021 | 1388 | 1.640 |
Why?
| | Female | 54 | 2021 | 3348 | 1.590 |
Why?
| | Echocardiography, Doppler, Color | 5 | 2016 | 5 | 1.500 |
Why?
| | Male | 48 | 2021 | 3276 | 1.470 |
Why?
| | Heart Failure | 4 | 2015 | 10 | 1.460 |
Why?
| | Heart Valve Prosthesis Implantation | 6 | 2020 | 6 | 1.400 |
Why?
| | Image Interpretation, Computer-Assisted | 6 | 2018 | 13 | 1.400 |
Why?
| | Aortic Rupture | 2 | 2016 | 2 | 1.330 |
Why?
| | Practice Guidelines as Topic | 3 | 2016 | 98 | 1.330 |
Why?
| | Aorta, Thoracic | 5 | 2016 | 10 | 1.290 |
Why?
| | Stroke Volume | 12 | 2018 | 14 | 1.270 |
Why?
| | Child, Preschool | 36 | 2018 | 1492 | 1.230 |
Why?
| | Heart Valve Prosthesis | 5 | 2020 | 5 | 1.190 |
Why?
| | Infant, Newborn | 29 | 2021 | 877 | 1.170 |
Why?
| | Hypoplastic Left Heart Syndrome | 9 | 2020 | 17 | 1.140 |
Why?
| | Heart Septal Defects, Atrial | 4 | 2006 | 4 | 1.140 |
Why?
| | Child | 42 | 2020 | 2792 | 1.120 |
Why?
| | Cardiomyopathies | 3 | 2015 | 6 | 1.000 |
Why?
| | Adolescent | 36 | 2020 | 1960 | 1.000 |
Why?
| | Treatment Outcome | 18 | 2020 | 618 | 0.960 |
Why?
| | Aortic Coarctation | 3 | 2016 | 4 | 0.940 |
Why?
| | Echocardiography, Transesophageal | 6 | 2012 | 9 | 0.920 |
Why?
| | Fontan Procedure | 8 | 2016 | 12 | 0.910 |
Why?
| | Reproducibility of Results | 18 | 2021 | 183 | 0.910 |
Why?
| | Heart Diseases | 6 | 2020 | 12 | 0.910 |
Why?
| | Heart | 4 | 2016 | 14 | 0.880 |
Why?
| | Ventricular Function, Right | 3 | 2016 | 3 | 0.880 |
Why?
| | Adult | 18 | 2018 | 1096 | 0.860 |
Why?
| | Image Enhancement | 3 | 2016 | 9 | 0.850 |
Why?
| | Ultrasonography, Prenatal | 5 | 2015 | 7 | 0.850 |
Why?
| | Pulmonary Artery | 8 | 2013 | 12 | 0.850 |
Why?
| | Cardiac Imaging Techniques | 2 | 2016 | 2 | 0.810 |
Why?
| | Cardiology | 7 | 2015 | 9 | 0.800 |
Why?
| | Aortic Stenosis, Supravalvular | 2 | 2016 | 2 | 0.750 |
Why?
| | Exercise | 2 | 2020 | 103 | 0.740 |
Why?
| | Sensitivity and Specificity | 12 | 2016 | 145 | 0.710 |
Why?
| | Follow-Up Studies | 17 | 2019 | 314 | 0.700 |
Why?
| | Patient Care Team | 2 | 2020 | 21 | 0.680 |
Why?
| | United States | 14 | 2020 | 624 | 0.670 |
Why?
| | Aortic Aneurysm | 1 | 2016 | 1 | 0.670 |
Why?
| | Sinus of Valsalva | 1 | 2016 | 1 | 0.670 |
Why?
| | Prospective Studies | 15 | 2020 | 470 | 0.650 |
Why?
| | Cardiology Service, Hospital | 1 | 2016 | 4 | 0.640 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 10 | 0.640 |
Why?
| | Heart Septal Defects, Ventricular | 4 | 2011 | 5 | 0.600 |
Why?
| | Telemedicine | 1 | 2016 | 55 | 0.570 |
Why?
| | Prognosis | 8 | 2021 | 180 | 0.550 |
Why?
| | Cardiomyopathy, Dilated | 4 | 2015 | 7 | 0.540 |
Why?
| | Magnetic Resonance Imaging | 6 | 2016 | 83 | 0.530 |
Why?
| | Echocardiography, Doppler | 7 | 2019 | 11 | 0.520 |
Why?
| | Palliative Care | 4 | 2020 | 16 | 0.490 |
Why?
| | Societies, Medical | 4 | 2016 | 43 | 0.480 |
Why?
| | Fetal Diseases | 2 | 2004 | 3 | 0.480 |
Why?
| | Retrospective Studies | 13 | 2021 | 1148 | 0.480 |
Why?
| | Aortic Diseases | 2 | 2013 | 4 | 0.460 |
Why?
| | Postoperative Complications | 6 | 2018 | 170 | 0.460 |
Why?
| | Ventricular Pressure | 3 | 2019 | 3 | 0.450 |
Why?
| | Risk Factors | 13 | 2021 | 403 | 0.450 |
Why?
| | Graft Rejection | 4 | 2015 | 30 | 0.440 |
Why?
| | Monitoring, Physiologic | 3 | 2020 | 23 | 0.440 |
Why?
| | Diastole | 7 | 2019 | 9 | 0.430 |
Why?
| | Predictive Value of Tests | 5 | 2021 | 101 | 0.420 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 12 | 0.420 |
Why?
| | Feasibility Studies | 7 | 2020 | 58 | 0.420 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2009 | 3 | 0.410 |
Why?
| | Vascular Malformations | 1 | 2009 | 2 | 0.410 |
Why?
| | Europe | 5 | 2016 | 30 | 0.410 |
Why?
| | Angiography | 1 | 2009 | 8 | 0.410 |
Why?
| | Ventricular Fibrillation | 1 | 2007 | 1 | 0.350 |
Why?
| | Young Adult | 10 | 2018 | 582 | 0.350 |
Why?
| | Ventricular Outflow Obstruction | 3 | 2018 | 3 | 0.350 |
Why?
| | Time Factors | 6 | 2018 | 277 | 0.340 |
Why?
| | Transposition of Great Vessels | 3 | 2011 | 5 | 0.330 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 16 | 0.330 |
Why?
| | Abnormalities, Multiple | 2 | 2008 | 34 | 0.330 |
Why?
| | Balloon Occlusion | 1 | 2005 | 1 | 0.310 |
Why?
| | Norwood Procedures | 3 | 2020 | 3 | 0.310 |
Why?
| | Stroke | 1 | 2005 | 17 | 0.310 |
Why?
| | Systole | 4 | 2015 | 6 | 0.310 |
Why?
| | Heart Atria | 2 | 2005 | 2 | 0.300 |
Why?
| | Internship and Residency | 2 | 2015 | 29 | 0.290 |
Why?
| | Survival Rate | 5 | 2007 | 79 | 0.290 |
Why?
| | Myocardium | 2 | 2015 | 9 | 0.270 |
Why?
| | Equipment Failure Analysis | 2 | 2014 | 4 | 0.270 |
Why?
| | Radiology, Interventional | 1 | 2003 | 1 | 0.270 |
Why?
| | Algorithms | 3 | 2015 | 95 | 0.260 |
Why?
| | Ultrasonography | 4 | 2013 | 42 | 0.260 |
Why?
| | Equipment Design | 4 | 2014 | 12 | 0.260 |
Why?
| | Myocardial Contraction | 3 | 2018 | 5 | 0.250 |
Why?
| | Embolization, Therapeutic | 1 | 2002 | 11 | 0.240 |
Why?
| | Pregnancy | 6 | 2009 | 251 | 0.240 |
Why?
| | Cardiovascular Diseases | 2 | 2013 | 45 | 0.240 |
Why?
| | Coronary Artery Disease | 3 | 2011 | 8 | 0.230 |
Why?
| | Oxygen | 2 | 2020 | 23 | 0.230 |
Why?
| | Telemetry | 1 | 2021 | 2 | 0.230 |
Why?
| | Prosthesis Design | 3 | 2020 | 7 | 0.230 |
Why?
| | Remote Consultation | 1 | 2021 | 4 | 0.230 |
Why?
| | Patient Admission | 1 | 2021 | 9 | 0.230 |
Why?
| | Adenoviridae Infections | 1 | 2001 | 1 | 0.230 |
Why?
| | Genome, Viral | 1 | 2001 | 4 | 0.230 |
Why?
| | Adenoviridae | 1 | 2001 | 4 | 0.230 |
Why?
| | Aortic Valve | 3 | 2016 | 3 | 0.230 |
Why?
| | Video Recording | 1 | 2021 | 14 | 0.230 |
Why?
| | Observer Variation | 5 | 2016 | 15 | 0.230 |
Why?
| | Coronary Vessels | 2 | 2011 | 3 | 0.220 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2011 | 7 | 0.220 |
Why?
| | Ductus Arteriosus, Patent | 2 | 2006 | 5 | 0.220 |
Why?
| | Heart Aneurysm | 1 | 2000 | 1 | 0.220 |
Why?
| | Home Nursing | 1 | 2020 | 1 | 0.220 |
Why?
| | Middle Aged | 4 | 2009 | 567 | 0.210 |
Why?
| | Weight Gain | 1 | 2020 | 23 | 0.210 |
Why?
| | Quality Improvement | 2 | 2020 | 64 | 0.210 |
Why?
| | Caregivers | 2 | 2020 | 37 | 0.210 |
Why?
| | Enteral Nutrition | 1 | 2020 | 55 | 0.200 |
Why?
| | Enalapril | 1 | 2019 | 1 | 0.200 |
Why?
| | Recovery of Function | 2 | 2018 | 16 | 0.200 |
Why?
| | Dilatation, Pathologic | 2 | 2016 | 6 | 0.200 |
Why?
| | Mitral Valve | 3 | 2007 | 3 | 0.190 |
Why?
| | Marfan Syndrome | 2 | 2013 | 3 | 0.190 |
Why?
| | Incidence | 6 | 2016 | 132 | 0.190 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 20 | 0.180 |
Why?
| | Home Care Services | 1 | 2018 | 8 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2018 | 31 | 0.180 |
Why?
| | Medical Records | 1 | 2018 | 15 | 0.180 |
Why?
| | Pulmonary Veins | 1 | 1998 | 1 | 0.180 |
Why?
| | Transplant Recipients | 1 | 2017 | 6 | 0.180 |
Why?
| | Exercise Test | 2 | 2015 | 8 | 0.180 |
Why?
| | Vascular Stiffness | 1 | 2016 | 5 | 0.170 |
Why?
| | Expert Testimony | 1 | 2016 | 3 | 0.170 |
Why?
| | Patient Care Bundles | 1 | 2016 | 3 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 44 | 0.160 |
Why?
| | Consensus | 1 | 2016 | 26 | 0.160 |
Why?
| | Anastomosis, Surgical | 4 | 2012 | 16 | 0.160 |
Why?
| | Remote Sensing Technology | 1 | 2016 | 4 | 0.160 |
Why?
| | Cloud Computing | 1 | 2016 | 5 | 0.160 |
Why?
| | Postoperative Care | 1 | 2016 | 29 | 0.160 |
Why?
| | Diffusion of Innovation | 1 | 2016 | 7 | 0.160 |
Why?
| | Attitude to Computers | 1 | 2016 | 5 | 0.160 |
Why?
| | Models, Organizational | 1 | 2016 | 9 | 0.160 |
Why?
| | Computers, Handheld | 1 | 2016 | 11 | 0.160 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 11 | 0.160 |
Why?
| | Program Evaluation | 1 | 2016 | 50 | 0.160 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 6 | 0.150 |
Why?
| | Clinical Competence | 3 | 2015 | 36 | 0.150 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 2 | 0.150 |
Why?
| | Multivariate Analysis | 4 | 2009 | 75 | 0.150 |
Why?
| | Aged | 3 | 2009 | 306 | 0.150 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2015 | 1 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 85 | 0.150 |
Why?
| | Advisory Committees | 1 | 2015 | 9 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2016 | 3 | 0.150 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 12 | 0.150 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 16 | 0.150 |
Why?
| | Neoplasms | 1 | 2016 | 93 | 0.150 |
Why?
| | Biomarkers | 2 | 2016 | 120 | 0.150 |
Why?
| | Internationality | 1 | 2014 | 5 | 0.140 |
Why?
| | Elasticity Imaging Techniques | 1 | 2014 | 3 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2020 | 124 | 0.140 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2014 | 5 | 0.140 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.140 |
Why?
| | Ultrasonography, Interventional | 2 | 2013 | 4 | 0.130 |
Why?
| | Aged, 80 and over | 2 | 2005 | 116 | 0.130 |
Why?
| | Severity of Illness Index | 3 | 2015 | 145 | 0.130 |
Why?
| | Biopsy | 2 | 2006 | 54 | 0.130 |
Why?
| | Ultrasonic Therapy | 1 | 2013 | 1 | 0.130 |
Why?
| | Cardiac Catheters | 1 | 2013 | 1 | 0.130 |
Why?
| | Body Mass Index | 1 | 2014 | 128 | 0.130 |
Why?
| | African Americans | 1 | 2014 | 109 | 0.130 |
Why?
| | Organ Size | 4 | 2012 | 19 | 0.120 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 79 | 0.120 |
Why?
| | Obesity | 1 | 2014 | 110 | 0.120 |
Why?
| | South Carolina | 3 | 2014 | 3 | 0.120 |
Why?
| | Data Display | 1 | 2012 | 1 | 0.120 |
Why?
| | Heart Valves | 1 | 2012 | 1 | 0.120 |
Why?
| | Bioprosthesis | 1 | 2011 | 1 | 0.120 |
Why?
| | Ventricular Function | 1 | 2011 | 1 | 0.120 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2011 | 1 | 0.120 |
Why?
| | Risk Assessment | 3 | 2021 | 138 | 0.120 |
Why?
| | Mitral Valve Insufficiency | 1 | 2011 | 1 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 35 | 0.110 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2011 | 2 | 0.110 |
Why?
| | Exercise Tolerance | 1 | 2010 | 4 | 0.110 |
Why?
| | Miniaturization | 1 | 2010 | 2 | 0.110 |
Why?
| | Treatment Failure | 2 | 2011 | 21 | 0.110 |
Why?
| | Coronary Disease | 2 | 2001 | 5 | 0.100 |
Why?
| | Septal Occluder Device | 1 | 2009 | 1 | 0.100 |
Why?
| | Stents | 1 | 2009 | 3 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2009 | 5 | 0.100 |
Why?
| | Chromosome Aberrations | 1 | 2009 | 4 | 0.100 |
Why?
| | Vitamin A | 1 | 1989 | 3 | 0.100 |
Why?
| | Cardiac Volume | 1 | 2009 | 1 | 0.100 |
Why?
| | Heart Septum | 2 | 2006 | 2 | 0.100 |
Why?
| | Decision Making | 1 | 2009 | 34 | 0.100 |
Why?
| | Heart Valve Diseases | 2 | 2007 | 2 | 0.100 |
Why?
| | Intensive Care Units | 1 | 2009 | 17 | 0.100 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2008 | 2 | 0.100 |
Why?
| | Reoperation | 3 | 2020 | 53 | 0.090 |
Why?
| | Mass Screening | 1 | 2008 | 40 | 0.090 |
Why?
| | Comorbidity | 3 | 2014 | 66 | 0.090 |
Why?
| | Parents | 1 | 2009 | 132 | 0.090 |
Why?
| | Disease Progression | 2 | 2021 | 92 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2007 | 17 | 0.090 |
Why?
| | Heart Bypass, Right | 1 | 2007 | 1 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 2005 | 13 | 0.090 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2007 | 1 | 0.090 |
Why?
| | Preoperative Care | 1 | 2007 | 26 | 0.090 |
Why?
| | Communication | 2 | 2020 | 47 | 0.080 |
Why?
| | Heart Septal Defects | 1 | 2006 | 1 | 0.080 |
Why?
| | Research Design | 1 | 2006 | 57 | 0.080 |
Why?
| | Heart Arrest | 1 | 2006 | 1 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2006 | 2 | 0.080 |
Why?
| | Pilot Projects | 2 | 2017 | 121 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 86 | 0.080 |
Why?
| | Regression Analysis | 2 | 2015 | 59 | 0.080 |
Why?
| | Medical Illustration | 1 | 2004 | 1 | 0.070 |
Why?
| | Congresses as Topic | 2 | 2015 | 9 | 0.070 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2004 | 2 | 0.070 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2004 | 2 | 0.070 |
Why?
| | Trisomy | 1 | 2004 | 2 | 0.070 |
Why?
| | Pregnancy Outcome | 1 | 2004 | 5 | 0.070 |
Why?
| | Prevalence | 2 | 2014 | 138 | 0.060 |
Why?
| | Equipment Safety | 1 | 2002 | 1 | 0.060 |
Why?
| | Device Removal | 1 | 2002 | 12 | 0.060 |
Why?
| | Pulmonary Circulation | 1 | 2002 | 1 | 0.060 |
Why?
| | Constriction, Pathologic | 1 | 2002 | 8 | 0.060 |
Why?
| | Pulmonary Atresia | 1 | 2001 | 1 | 0.060 |
Why?
| | Patient Selection | 1 | 2002 | 46 | 0.060 |
Why?
| | Vasodilator Agents | 1 | 2001 | 3 | 0.060 |
Why?
| | Educational Measurement | 2 | 2015 | 7 | 0.060 |
Why?
| | Curriculum | 2 | 2015 | 20 | 0.060 |
Why?
| | Forecasting | 2 | 1998 | 20 | 0.060 |
Why?
| | Safety | 2 | 1998 | 20 | 0.060 |
Why?
| | Health Status | 1 | 2021 | 23 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2001 | 38 | 0.060 |
Why?
| | Hypertension | 2 | 1998 | 54 | 0.060 |
Why?
| | Logistic Models | 2 | 2013 | 95 | 0.060 |
Why?
| | Virus Diseases | 1 | 2001 | 12 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2001 | 98 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2013 | 275 | 0.050 |
Why?
| | American Heart Association | 1 | 2020 | 1 | 0.050 |
Why?
| | Transitional Care | 1 | 2020 | 2 | 0.050 |
Why?
| | Checklist | 1 | 2020 | 6 | 0.050 |
Why?
| | Oximetry | 1 | 2020 | 9 | 0.050 |
Why?
| | Accelerometry | 1 | 2020 | 38 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2020 | 10 | 0.050 |
Why?
| | Infant, Newborn, Diseases | 1 | 2000 | 31 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 10 | 0.050 |
Why?
| | Patient Discharge | 1 | 2020 | 56 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2019 | 44 | 0.050 |
Why?
| | Graft Survival | 2 | 1998 | 30 | 0.050 |
Why?
| | Phenotype | 1 | 2020 | 217 | 0.050 |
Why?
| | Quality of Life | 1 | 2020 | 100 | 0.050 |
Why?
| | Registries | 2 | 2013 | 84 | 0.050 |
Why?
| | Compassionate Use Trials | 1 | 2018 | 1 | 0.050 |
Why?
| | Angioplasty, Balloon | 1 | 1998 | 1 | 0.050 |
Why?
| | Dobutamine | 1 | 1998 | 1 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 5 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 1998 | 35 | 0.050 |
Why?
| | Hospitals, University | 1 | 2018 | 3 | 0.050 |
Why?
| | Linear Models | 1 | 1998 | 58 | 0.050 |
Why?
| | Videotape Recording | 1 | 1998 | 3 | 0.050 |
Why?
| | Recurrence | 1 | 1998 | 104 | 0.050 |
Why?
| | Pericardium | 1 | 1997 | 6 | 0.040 |
Why?
| | Cohort Studies | 1 | 2018 | 259 | 0.040 |
Why?
| | Troponin I | 1 | 2016 | 3 | 0.040 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2016 | 5 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2016 | 17 | 0.040 |
Why?
| | Survivors | 1 | 2016 | 16 | 0.040 |
Why?
| | Boston | 1 | 2016 | 1 | 0.040 |
Why?
| | Blood Volume | 1 | 2016 | 4 | 0.040 |
Why?
| | Manometry | 1 | 2016 | 3 | 0.040 |
Why?
| | Sodium Chloride | 1 | 2016 | 3 | 0.040 |
Why?
| | Reference Standards | 1 | 2016 | 14 | 0.040 |
Why?
| | Causality | 1 | 2016 | 10 | 0.040 |
Why?
| | North America | 1 | 2016 | 43 | 0.040 |
Why?
| | Missouri | 1 | 2016 | 90 | 0.040 |
Why?
| | Life Tables | 1 | 1995 | 2 | 0.040 |
Why?
| | Survival Analysis | 2 | 2007 | 47 | 0.040 |
Why?
| | Down Syndrome | 1 | 1995 | 27 | 0.040 |
Why?
| | Reference Values | 1 | 2015 | 45 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 29 | 0.040 |
Why?
| | Fetal Heart | 1 | 2015 | 2 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2015 | 3 | 0.040 |
Why?
| | Teaching | 1 | 2015 | 4 | 0.040 |
Why?
| | Goals | 1 | 2015 | 6 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 9 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 19 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 183 | 0.030 |
Why?
| | Atenolol | 1 | 2013 | 1 | 0.030 |
Why?
| | Losartan | 1 | 2013 | 1 | 0.030 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 1 | 0.030 |
Why?
| | Technology Assessment, Biomedical | 1 | 2013 | 1 | 0.030 |
Why?
| | Bioengineering | 1 | 2013 | 1 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 6 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2013 | 3 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2013 | 9 | 0.030 |
Why?
| | Research | 1 | 2013 | 9 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2013 | 8 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2013 | 28 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2013 | 5 | 0.030 |
Why?
| | Software | 1 | 2013 | 15 | 0.030 |
Why?
| | Blalock-Taussig Procedure | 1 | 2012 | 1 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2011 | 2 | 0.030 |
Why?
| | Transplantation, Homologous | 2 | 2004 | 13 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2010 | 7 | 0.030 |
Why?
| | Postoperative Period | 1 | 2010 | 17 | 0.030 |
Why?
| | Acute Disease | 1 | 2011 | 65 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2011 | 35 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2010 | 13 | 0.030 |
Why?
| | Amniocentesis | 1 | 2009 | 1 | 0.030 |
Why?
| | Maternal Age | 1 | 2009 | 1 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2009 | 15 | 0.030 |
Why?
| | Retinol-Binding Proteins | 1 | 1989 | 1 | 0.030 |
Why?
| | Vitamin A Deficiency | 1 | 1989 | 1 | 0.030 |
Why?
| | Fetal Blood | 1 | 1989 | 5 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 1989 | 9 | 0.030 |
Why?
| | Odds Ratio | 1 | 2009 | 47 | 0.030 |
Why?
| | Pacemaker, Artificial | 1 | 2008 | 1 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2008 | 6 | 0.020 |
Why?
| | Tachycardia | 1 | 2008 | 3 | 0.020 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 2 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2007 | 4 | 0.020 |
Why?
| | Models, Statistical | 1 | 2007 | 30 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2005 | 1 | 0.020 |
Why?
| | Aortic Valve Stenosis | 1 | 2005 | 2 | 0.020 |
Why?
| | Vascular Resistance | 1 | 2005 | 7 | 0.020 |
Why?
| | Fetus | 1 | 2005 | 24 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2004 | 7 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2005 | 79 | 0.020 |
Why?
| | Hemodynamics | 1 | 2004 | 12 | 0.020 |
Why?
| | Canada | 1 | 2004 | 33 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2004 | 31 | 0.020 |
Why?
| | Animals | 1 | 2005 | 869 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2001 | 41 | 0.010 |
Why?
| | Magnetic Resonance Angiography | 1 | 2001 | 6 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2001 | 16 | 0.010 |
Why?
| | Infant, Premature | 1 | 2001 | 122 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 1998 | 1 | 0.010 |
Why?
| | Coronary Angiography | 1 | 1998 | 1 | 0.010 |
Why?
| | Cause of Death | 1 | 1998 | 12 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1997 | 3 | 0.010 |
Why?
| | Surgical Flaps | 1 | 1997 | 6 | 0.010 |
Why?
| | Cryopreservation | 1 | 1996 | 5 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|